Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer.

BMC Cancer · 2011 · PMC3235081 · PMID 22117530

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.3000

boldest claim

The sentences

at the limit of significancep = 0.050actually significant

The influence of CCDN1 A870G polymorphism was at the limit of significance (AA vs AG vs GG, p = 0.050, Figure 6 ), with GG patients exhibiting the poorest survival.

also in 326 other papers

did not reach statistical significancep = 0.30not close (p > 0.1)

Even though response rate was greater in patients developing cutaneous toxicity (13.9% in patients with grade 2-3 vs 5.0% in patients with grade 0-1), this difference did not reach statistical significance (p = 0.30).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.